Progressive osseous muscle inflammation

M13_PROGRESSIVE_OSSEOUS_MUSCLE_INFLAMMATION

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M61.1 Cause of death: ICD-10 — M61.1 2 out of 7 registries used, show all original rules.	50
4. Check minimum number of events None	50
5. Include endpoints None	50
6. Filter based on genotype QC (FinnGen only)	50

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

NAME	M13_PROGRESSIVE_OSSEOUS_MUSCLE_INFLAMMATION
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M611
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M611
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Progressive osseous muscle inflammation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	50	24	26
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	61.15	58.82	63.30

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
50: Matched controls
500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M61.1

ICD-10 Finland

Myositis ossificans progressiva

+∞

71.5

M16.1

ICD-10 Finland

Other primary coxarthrosis

25.1

31.1

NF1AA

NOMESCO Finland

Hip X-ray examination

11.1

9.6

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

11.6

9.0

M48.0

ICD-10 Finland

Spinal stenosis

6.3

8.2

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

26.8

6.9

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

5.6

6.7

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

8.8

6.2

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

13.5

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

184

3.05

3.50

4.8

6.6

0.04

e9/l

0.27

158

(3019198) Lymphocytes [#/volume] in Blood

190

2.90

3.21

4.8

6.6

1.62

1.71

e9/l

0.29

167

(3042936) Bacteria identified in Isolate by Culture

3.20

3.14

2.7

2.2

—

(3001604) Monocytes [#/volume] in Blood

185

2.78

3.01

4.9

6.4

0.57

0.59

e9/l

0.28

159

(3013115) Eosinophils [#/volume] in Blood

192

2.62

2.70

5.0

6.7

0.22

0.17

e9/l

0.83

166

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

7.77

2.61

1.8

1.0

—

(3026008) Bacteria identified in Urine by Culture

135

2.50

2.51

5.9

3.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

162

2.45

2.44

2.9

2.0

99.90

95.46

pmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

130

2.42

2.35

2.7

2.6

—

(3044889) 12 lead EKG panel

271

2.41

1.96

5.6

4.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

193

2.20

1.92

3.0

2.5

—

(40758558) Short blood count panel - Blood

2.28

1.89

3.3

8.8

—

(3012516) Albumin [Mass/volume] in Urine

125

2.17

1.82

4.1

3.0

2788.46

74.11

mg/l

0.46

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

215

2.16

1.82

8.1

7.3

1.20

mmol/l

0.22

184

(3019309) Folate [Moles/volume] in Red Blood Cells

2.27

1.76

1.7

1312.63

1273.52

nmol/l

0.04

(3009508) Creatinine [Moles/volume] in Urine

127

2.13

1.73

3.9

3.0

8.13

8.51

mmol/l

0.15

102

(40760892) CBC W Ordered Manual Differential panel - Blood

180

2.09

1.73

5.9

6.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.58

1.68

1.3

2.6

1.63

1.75

—

(3045414) Leukocytes [Presence] in Urine

3.35

1.47

1.6

1.9

—

(3023368) Bacteria identified in Blood by Culture

134

1.98

1.46

5.7

4.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

135

1.96

1.42

4.0

3.7

0.80

10.98

mg/mmol

1.93

(3037467) Urinalysis macro (dipstick) panel - Urine

281

2.00

1.35

7.6

4.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.30

1.32

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

130

1.90

1.29

4.2

4.4

25.62

22.69

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.25

1.27

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.48

1.22

2.3

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

393

2.45

1.19

28.0

17.4

31.76

26.22

mg/l

0.46

313

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.66

1.18

2.6

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.46

1.16

1.1

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

100

1.88

1.14

2.2

2.5

—

(3000494) Fungus identified in Specimen by Culture

2.22

1.12

1.0

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1.97

1.08

1.2

1.6

3.51

2.86

g/l

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

164

1.75

1.07

3.5

2.3

202.91

128.20

ug/l

0.28

142

(3022145) Colonoscopy Study observation

2.07

0.94

1.4

1.3

—

(3002256) Pathology report gross observation

1.97

0.91

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.13

0.90

4.0

2.0

0.00

0.12

e6/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2.06

0.87

6.3

1.4

2.03

1.92

—

(3022621) pH of Urine by Test strip

1.99

0.85

2.2

3.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

109

1.69

0.84

3.9

3.7

—

(3009261) Glucose [Presence] in Urine by Test strip

222

1.59

0.81

6.3

4.1

0.00

estimate

—

(3015736) pH of Urine

174

1.60

0.81

6.0

3.8

—

5.75

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

0.81

0.0

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.76

0.80

2.0

1.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.79

0.79

7.9

7.6

104.27

103.85

mmol/l

0.19

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.68

0.77

2.2

3.4

2.43

2.47

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

137

0.58

0.74

2.7

3.5

—

(36660697) Celiac disease serology panel - Serum

1.87

0.68

1.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

219

1.51

0.66

6.3

4.1

0.00

estimate

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1.60

0.65

1.1

1.8

334.78

498.35

pmol/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

172

1.50

0.64

5.5

3.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.57

0.61

8.4

9.6

—

(3019225) pH of Specimen

1.81

0.60

6.3

4.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.59

0.58

3.4

2.4

0.73

0.84

e6/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

156

1.47

0.58

2.7

3.2

2.32

2.35

mmol/l

0.35

135

(3007853) Bacteria identified in Skin by Aerobe culture

1.66

0.56

2.2

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

224

1.45

0.56

7.7

5.5

0.00

estimate

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.56

0.56

2.0

3.8

0.84

0.81

mmol/l

0.59

(3019060) Gas panel - Arterial blood

1.61

0.55

5.0

3.8

—

(40768804) Tissue Pathology biopsy report

148

1.46

0.55

1.9

1.8

—

(36304419) Bacteria [Presence] in Urine

140

1.45

0.52

4.6

2.8

—

(3013512) EKG study

123

1.44

0.48

4.8

5.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.68

0.44

3.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

355

1.45

0.42

5.8

4.5

1.84

1.99

mu/l

0.43

306

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.42

0.0

2.8

—

6.93

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.42

0.0

2.8

—

1.28

—

(40761535) Cells panel - Urine sediment

1.52

0.41

3.8

4.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.39

0.41

3.1

1.9

12.07

14.15

umol/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

178

1.31

0.34

4.9

4.2

40.46

30.05

ng/l

0.26

140

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

289

1.30

0.31

4.9

3.7

14.40

15.10

pmol/l

0.71

252

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

210

1.27

0.30

3.0

2.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

417

1.46

0.26

28.9

20.1

76.02

82.31

umol/l

0.76

417

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

397

1.36

0.24

5.7

5.2

2.51

2.60

mmol/l

0.28

348

(3029937) Albumin [Presence] in Urine by Test strip

127

1.26

0.23

8.5

4.0

0.00

estimate

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

388

1.31

0.23

5.9

4.7

6.05

6.02

mmol/l

0.08

338

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

386

1.34

0.23

4.2

4.6

1.38

1.44

mmol/l

0.36

340

(3000991) Gas panel - Venous blood

1.24

0.23

7.2

10.0

—

(3003694) ABO and Rh group [Type] in Blood

1.28

0.22

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.21

0.22

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

2.4

—

107.40

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

2.4

—

3.97

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

6.4

—

2242.71

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

2.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.28

0.21

9.2

3.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.28

0.21

2.0

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.20

0.0

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

118

0.81

0.16

9.9

3.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

373

1.21

0.14

3.7

4.1

1.31

1.28

mmol/l

0.11

325

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.13

0.09

1.8

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

382

0.88

0.08

26.4

17.2

77.03

75.50

ml/min/173m2

0.14

307

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

170

1.09

0.05

7.6

4.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

134

1.06

0.01

2.8

2.2

44.57

54.29

u/l

1.07

123

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

12.67

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

2.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

0.0

1.8

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.3

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.7

—

34.33

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

2.5

—

62.25

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.02

0.00

7.6

5.4

1.14

0.99

mmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.04

-0.00

2.7

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

1.8

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

8.90

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

7.8

—

126.80

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.2

—

16.20

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.3

—

180.51

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

3.8

—

18.67

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.4

—

(3008898) HLA-B27 [Presence]

0.00

-0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

2.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

5.44

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

2.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

12.58

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

3.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: M13_PROGRESSIVE_OSSEOUS_MUSCLE_INFLAMMATION – Progressive osseous muscle inflammation

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Progressive osseous muscle inflammation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Progressive osseous muscle inflammation (M13_PROGRESSIVE_OSSEOUS_MUSCLE_INFLAMMATION)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints